King Wealth Management Group
Position in GILD — Gilead Sciences, Inc.
CIK 1568235
SARATOGA SPRINGS, NY
Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$238,150
-$2,263 QoQ
Shares Held
1,885
+9.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,813
of 2,266 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026King Wealth Management Group holds $17,091,631 across 9 Drug Manufacturers - General names. GILD ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,913 | $9,491,090 | |
| 2 | JNJ |
Johnson & Johnson
|
15,202 | $3,860,851 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,948 | $1,021,318 | |
| 4 | ABBV |
AbbVie Inc.
|
2,709 | $681,692 | |
| 5 | NVS |
Novartis AG
|
3,251 | $509,496 | |
| 6 | PFE |
Pfizer Inc
|
19,427 | $467,802 | |
| 7 | AMGN |
Amgen Inc
|
1,179 | $426,939 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,843 | $394,293 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,150 | 1,885 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $240,413 | 1,725 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $206,694 | 1,684 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $234,432 | 2,112 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $234,046 | 2,111 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $236,425 | 2,110 | Shares | Sole | 2025-05-08 | |
| 2020-06-30 | $208,045 | 2,704 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $201,852 | 2,700 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||